Integrated DNA Technologies

Two German-Based Sister Companies Plans to Develop Workflows for Use of 454 Sequencing Systems in Human Genetics
IMGM Laboratories and the Center for Human Genetics and Laboratory Medicine will use the GS FLX System and GS Junior System for the joint development program.

Parent Project Muscular Dystrophy Awards $600K to Nationwide Children's Hospital for Gene Therapy Study
Dr. Jerry Mendell to lead follistatin gene therapy for Duchenne muscular dystrophy.

Biosearch Technologies Expands Licensing of QIAGEN Scorpions®
According to the agreement, the company obtains rights to manufacture primer assays for research, applied markets and infectious diseases.

Idaho Technology Issues License to DuPont Qualicon
Agreement extends Idaho’s ongoing program to license its intellectual property portfolio in cooperation with Roche Diagnostics

NEW TECHNOLOGIES FOR FFPE SAMPLES: Improved RNA Isolation and novel cDNA priming for qPCR and for universal mRNA amplification
1AmpTec GmbH, Hamburg, Germany; 2Department of Clinical Research, University of Bern, Switzerland; 3Xceed Molecular, Toronto, Canada; 4Department of Dentistry, UKSH, Kiel, Germany

Improved FFPE RNA isolation, novel TR priming for complete recovery of FFPE mRNA fragments. Differential expression defines Scores for tumor classification: comparing fresh-frozen with FFPE. Novel flow-through Ziplex microarray platform demonstrates MAQC performance level of data obtained with FFPE samples.

FOXP3 Gene Expression in Multiple Sclerosis patients before and after Mesenchymal Stem Cell therapy
Tehran University of Medical Sciences,University of Tehran

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disorder of the CNS. No successful treatment for MS, but one therapeutic strategy in research is the use of bone marrow-derived mesenchymal stem cells (MSC). We studied a group of MS patients who underwented MSCs, assayed for expression of a transcription factor, FOXP3, as a specific marker of MS amelioration in peripheral blood. qRT-PCR on PBMCs showed higher FoxP3 levels.

Protein NMR/Biophysics Research Associate (BS/MS)
Novartis Institutes for BioMedical Research
We are committed to discovering innovative medicines to cure disease and improve human health. By hiring the best academic, biotech, and pharmaceutical trained scientists, we have fostered an atmosphere for drug discovery where innovation is rewarded.

Senior Account Manager/Account Director
Alto Marketing
The best career move for a well-connected marketing professional with real leadership ability and drive!

Senior Scientific Marketing Writer - Life Sciences
Alto Marketing
For a challenging career using your advanced life science background and writing strengths, please read on.

Post-doctoral position at INRA (France)
INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants.

Engineer Technician, Fayetteville, Arizona, USA
SFC-Fluidics
SFC Fluidics is looking to hire a highly motivated, detail-oriented engineer technician.

oral communication skills . Experience with GMP and GLP desired

Computational Medicinal Chemistry Post-Doc Position, Siena, Italy
University of Siena
NatSynDrugs Is Seeking Candidates For a Computational Medicinal Chemistry Post-Doc Position

Automation Engineer, Metabolism, Agios Pharmaceuticals, Cambridge, MA, USA
Agios Pharmaceuticals
With new research showing that cancer cells become addicted to using more nutrients than normal cells to promote their rapid growth, there is an unprecedented opportunity to create a new class of oncology therapeutics that target a fundamental and ubiquitous mechanism in cancer cells. The intersection of these two fields of research - cancer and metabolism- represents an important and novel approach to treating cancer.


Advances in qPCR
14 September 2010 - 15 September 2010

Now in its 3rd year, this conference will discuss the latest techniques and platforms for qPCR as well as highlighting some of the uses of qPCR for current research including Biomarker Discovery, Medical Diagnostics and Profiling and microRNA and siRNA studies.

Epigenetics Europe
14 September 2010 - 15 September 2010

The second Epigenetics Europe will focus on the most recent discoveries in this field. Speakers will discuss Methylation and DNA silencing, Chromatin remodelling and ncRNA functions as well as highlighting some of the discoveries of epigenetics in disease processes.
  


Quantitative Multiplex Analysis Using a Novel Universal Real-time Transcription-Mediated Amplification–based Format

Norman C. Nelson, Director of Biochemistry, Gen-Probe, speaking at Molecular Diagnostics World Congress 2009


Improvement of Sensitivity of Molecular Diagnostics by replacing PCR with Cold-PCR

Mike G. Makrigiorgos, Associate Professor, Director Biophysics Laboratory, Dana Farber Cancer Institute, speaking at Molecular Diagnostics World Congress 2009


A Nanofluidic Real Time PCR Array for the 7900HT PCR System

Jing Wang, Senior Chip Scientist, Fluidigm Corporation, speaking at Lab-on-a-Chip World Congress 2009

Efficient Delivery of Thermo Scientific Dharmacon SMARTpool siRNA Reagents in Difficult-to-Transfect Cell Lines Using Nucleofector® 96-well Shuttle® System
Lonza

siRNA-mediated gene knockdown is a powerful tool that has been used to identify gene function and elucidate biological pathways. Successful siRNA experiments involving knockdown of individual genes or collections of gene targets require efficient delivery of highly functional and specific siRNA molecules into appropriate cells.

Multiplexed Diagnostics 2010
Select Biosciences Ltd

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.

qPCR Assay Trends 2010
HTStec

This market report summarizes the results of HTStec’s 2nd industry-wide global web-based benchmarking survey on real-time quantitative PCR (qPCR) assays and instruments carried out in April 2010.